Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance

MLA

Miguel Lemos, et al. “Targeting α-Synuclein by PD03 AFFITOPE® and Anle138b Rescues Neurodegenerative Pathology in a Model of Multiple System Atrophy: Clinical Relevance.” Translational Neurodegeneration, vol. 9, no. 1, Sept. 2020, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s40035-020-00217-y.

APA

Miguel Lemos, Serena Venezia, Violetta Refolo, Antonio Heras-Garvin, Sabine Schmidhuber, Armin Giese, Andrei Leonov, Sergey Ryazanov, Christian Griesinger, Gergana Galabova, Guenther Staffler, Gregor Karl Wenning, & Nadia Stefanova. (2020). Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance. Translational Neurodegeneration, 9(1), 1–14. https://doi.org/10.1186/s40035-020-00217-y

Chicago

Miguel Lemos, Serena Venezia, Violetta Refolo, Antonio Heras-Garvin, Sabine Schmidhuber, Armin Giese, Andrei Leonov, et al. 2020. “Targeting α-Synuclein by PD03 AFFITOPE® and Anle138b Rescues Neurodegenerative Pathology in a Model of Multiple System Atrophy: Clinical Relevance.” Translational Neurodegeneration 9 (1): 1–14. doi:10.1186/s40035-020-00217-y.